The choice between mechanical and bioprosthetic mitral valve replacement (MVR) remains debated. Mechanical valves carry a risk of thromboembolism, while bioprostheses degenerate and require more reintervention, yet the use of bioprosthetic continues to rise. This population-wide Ontario study, the largest retrospective comparison to date, included all adults undergoing first-time MVR (1991–2014), with up to 25 years of follow-up. The primary outcome was all-cause mortality, while secondary outcomes included major adverse valve-related events. Inverse probability of treatment weighting adjusted for baseline differences.
You are here:
Long-Term Outcomes of Mechanical Vs Bioprosthetic Mitral Valve Replacement
Submitted by: EACTS Staff
Source: European Journal of Cardio-Thoracic Surgery
Source URL: https://doi.org/10.1093/ejcts/ezag201
Keywords:
Author(s): Luke J. Rogers, Derrick Y. Tam, Anna Chu, Douglas S. Lee, Terrence M. Yau, Tirone E. David, Piroze M. Davierwala
